ASTRO Annual Meeting | Conference

Combining Radiotherapy With Anti-Androgen Improves Prostate Cancer Survival

October 24th 2015

The additon of hormonal therapy to salvage radiotherapy demonstrated a significant survival benefit in patients with prostate cancer recurrence after radical prostatectomy, according to long-term follow-up data from a randomized trial.

Enhanced Immune Response Seen With Radiation/Ipilimumab Combo in Melanoma

October 24th 2015

Proinflammatory cytokines were elevated in patients with melanoma undergoing the combination treatment of radiation therapy and the systemic anti–CTLA-4 immunotherapy, ipilimumab.

Dr. Johung on Prognosis of Patients With ALK-Rearranged NSCLC and Brain Metastases

October 23rd 2015

Kimberly L. Johung, MD, PhD, assistant professor of Therapeutic Radiology, Gastrointestinal Cancer Program, Yale Cancer Center, discusses a study that examined the prognosis of patients with ALK-rearranged non–small cell lung cancer and brain metastases.

Radiation Underutilized in Low-Grade Follicular Lymphoma

October 22nd 2015

The use of radiation therapy has declined despite evidence demonstrating it is often more beneficial than single-agent chemotherapy or observation-alone in patients with low-grade follicular lymphoma.

Dr. Fernandez Discusses Immunotherapy Plus Radiation Therapy for Prostate Cancer

October 6th 2014

Eduardo Fernandez, MD, PhD, FACRO, Senior Vice President, Medical Affairs / Medical Director for Latin America, Radiation Oncologist, 21st Century Oncology, discusses the potential for immunotherapy and radiation therapy to be used together to treat prostate cancer.

Dr. Fitch Discusses Dose Escalation of Radiation in Prostate Cancer

September 26th 2014

Dwight L. Fitch, MD, Radiation Oncologist, 21st Century Oncology in Bradenton, Florida, discusses dose modifications for radiation therapy in patients with prostate cancer.

Gustavo Olivera, PhD, Discusses an Analysis of a Radiation Oncology Registry

September 23rd 2014

Gustavo Olivera, PhD, from 21st Century Oncology, discusses an analysis of a radiation oncology registry.

Dr. Mehta Discusses the Reliability of Automated Segmentation for Lung Volumes in Multiple Cancers

September 23rd 2014

Niraj Mehta, MD, Radiation Oncologist, 21st Century Oncology, discusses the reliability of automated segmentation for lung volumes in breast, lung, and esophageal cancers.

Daniel H. Galmarini Provides an Overview of Adaptive Radiotherapy

September 19th 2014

Daniel H. Galmarini, Chief Technology Officer/Director, Physics and Engineering, 21st Century Oncology, provides an overview of adaptive radiotherapy.

Blood-Based Biomarkers Predict Outcomes Following Neoadjuvant Treatment in Esophageal Cancer

September 16th 2014

High pretreatment levels of serum VEGF-A and TGF-β1 indicated significantly worse disease-free survival (DFS) following neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.

Aggressive Treatment Leads to Long-Term Survival in Low-Risk Stage IV NSCLC

September 16th 2014

Timing of metastatic development, lymph node involvement, and type of disease all factor into the overall survival rate of patients with stage IV NSCLC.

Potentially Curative Surgery Achievable With Chemo/SABR Combination for Advanced Pancreatic Cancer

September 16th 2014

The combination of chemotherapy and stereotactic ablative radiotherapy (SABR) may allow patients with locally advanced pancreatic cancer to undergo surgery, a procedure that might not have otherwise been an option

Vessel-Sparing Radiation Preserves Sexual Function in Men With Prostate Cancer

September 16th 2014

With the use of MRI imaging to restrict doses to erectile tissues, nearly half of men treated with external beam radiation therapy (EBRT) for prostate cancer were able to be sexually active without aids or medications 5 years later, and nearly 80% could be sexually active if such support was an option

Abbreviated Course of ADT + Radiation Improves QoL in High-Risk Prostate Cancer

September 16th 2014

When given along with radiation therapy to men with high-risk prostate cancer, 18 months of androgen-deprivation therapy (ADT)-as opposed to a 36-month course-not only generates similar long-term outcomes, but results in a better quality of life

Radiotherapy Without Chemo Can Ease Dysphagia in Patients With Advanced Esophageal Cancer

September 15th 2014

Radiotherapy is equally as effective in the palliation of dysphagia (difficulty swallowing) as chemoradiotherapy for patients with advanced esophageal cancer

Radiation Therapy Improves Survival in Hodgkin's Lymphoma

September 15th 2014

Despite a recent decline in utilization, consolidated radiation therapy has been shown to improve 10-year survival rates for patients with stage I/II Hodgkin's lymphoma following treatment with chemotherapy

NEXT PAGE
PREVIOUS PAGE